LGND - Ligand Pharmaceuticals's CEO Davis Todd increases shareholding
2023-09-25 17:28:21 ET
More on Ligand Pharmaceuticals
- Seeking Alpha’s Quant Rating on Ligand Pharmaceuticals
- Historical earnings data for Ligand Pharmaceuticals
- Financial information for Ligand Pharmaceuticals
- Novan craters as company files for bankruptcy, to sell most of its assets
For further details see:
Ligand Pharmaceuticals's CEO Davis Todd increases shareholding